<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

Biotech_Leaders_horizontal_white

 

Showcase stage

Open to private & public drug discovery & development companies with a therapeutic pipeline or platform technology across all therapeutic areas & modalities. 

DOWNLOAD BROCHURE

BOOK TICKETS

3 reasons to  showcase

Sponsored by:
Merck Logo

 

LSX World Biotech Key Reasons 01 Present to investors

500+ Investors & strategic partners will attend the LSX World Congress. 

LSX World Biotech Key Reasons 02Increase brand awareness

The showcase stages are placed right in the middle of the floor to ensure maximum visibility

LSX World Biotech Key Reasons 03More 1-2-1 meetings

Showcasing companies are more visible pre-event and onsite. Stats show showcasing companies book 20% more meetings.

Biotech Showcase Agenda

Day 1 – Wednesday 3rd May

10:30 Ymmunobio (2)  

10:45 IAMA Therapeutics

 


11:00 Amyl Therapeutics

 


11:15 Lisata Therapeutics (1)

 


11:30 invIOs (1)

 

Expert Investor Panel

  • Nadiya Ishnazarova, Associate, M Ventures
  • Jonathan Tobin, Partner, Brandon Capital Partners
  • Farzad Abdi-Dezfuli, Partner, Sarsia Seed

Nadiya Ishnazarova, Associate, M Ventures  Jonathan Tobin, Investment Director, Brandon Capital Partners  Farzad Abdi-Dezfuli, Partner, Sarsia Seed (1)


11:45 Memo Therapeutics

 


12:00 _Cleara Biotech

 


12:15 Kither Biotech (1)

 


12:30 Versameb (1)

 

Expert Investor Panel

  • Katherine Cohen, Venture Partner, Panacea Venture
  • Andreas Jurgeit, Partner, Gimv
  • Gonzalo Garcia, Partner, Syncona Limited

Katherine Cohen, Venture Partner, Panacea Venture  Andreas Jurgeit, Partner, Lundbeckfonden  Gonzalo Garcia, Partner, Syncona Limited


Lunch  

14:00 Lytix Biopharma

 


14:15 Evaxion Biotech Logo

 


14:30 Tetraneuron

 


14:45 Hemispherian-1

 


15:00 Molecure

 

Expert Investor Panel

  • Oliver Colville, Associate, Apeiron Investment Group
  • Melisa Guven, Associate, Monograph Capital Partners
  • To join this panel please contact steph@lsxleaders.com 
Oliver Colville, Associate, Apeiron Investment Group Melisa Guven, Associate Monograph Capital Partners

15:15 Pan Cancer T

 


15:30   Normax

 


15:45 T-Curx   15:45  

 
16:00 TME Pharma (1)   16:00  

 
16:15 Sitryx Therapeutics   16:15

 


 
16:30 Sibylla Biotech   16:30  

 
16:45 immunitrack   16:45

 


 
17:00 InnoMedica Logo

 

17:00

 

 
17:15 OSE Immunotherapeutics

 

17:15

Fitabeo Therapeutics

 
17:30 Resolution Therapeutics (3)   17:30 Rappta Therapeutics

Day 2 – Thursday 4th May

10:30 Rejuvenate Biomed

 

  10:30 ATZ therapeutics

 


 
10:45 PharmNovo-1

 

  10:45 Makana Therapeutics

 


 
11:00 Diaccurate

 

  11:00 Deciduous Therapeutics

 


 
11:15 Pleco Therapeutics

 

  11:15 Tubulis

 


 
11:30 Liminal Biosciences

 

  11:30 Novai

 

Expert Investor Panel

  • Daniel O'Mahony, Partner, Seroba Life Sciences
  • Gabor Heltovics, Venture Partner, NLC Health
  • Lars Mørland Knudsen, Investment Director, P53 Invest

Daniel_OMahony_Seroba  Gabor Heltovics, Venture Partner, NLC Health  Lars Mørland Knudsen, Investment Director, P53 Invest

     

 
11:45 Abarceo Pharma

 

  11:45 STALICLA

 


 
12:00

Diamyd Medical-1

 

 

12:00

Alma Therapeutics

 


 
12:15

Mitotech Logo

 

12:15

Slate Therapeutics

 


 
12:30

GeNeuro

 

 

12:30

Alma Therapeutics

 


 
12:45 Scenic Biotech   12:45 StemMedical

 

  

 

 

DOWNLOAD BROCHURE